Clinical Trials Directory

Trials / Completed

CompletedNCT00754429

The Effect of Losartan Versus Amlodipine-based Therapy in Ischemic Stroke (0954-338)(COMPLETED)

The Effect of Losartan Versus Amlodipine-based Antihypertensive Therapy on Atherosclerotic Inflammatory Markers and Cerebrovascular Regulation in Ischemic Stroke Patients

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Taipei Veterans General Hospital, Taiwan · Other Government
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

To compare the effect of losartan vs amlodipine-based antihypertensive therapy on atherosclerotic inflammatory markers and cerebrovascular regulation in Ischemic stroke patients.

Conditions

Interventions

TypeNameDescription
DRUGlosartanlosartan 50mg qd for 30 weeks.
DRUGamlodipineamlodipine 5 mg q.d for 30 weeks.

Timeline

Start date
2004-06-01
Primary completion
2009-06-01
Completion
2009-07-01
First posted
2008-09-18
Last updated
2013-10-23

Source: ClinicalTrials.gov record NCT00754429. Inclusion in this directory is not an endorsement.

The Effect of Losartan Versus Amlodipine-based Therapy in Ischemic Stroke (0954-338)(COMPLETED) (NCT00754429) · Clinical Trials Directory